Seattle, WA, United States of America

Fuqiang Ruan


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1995-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fuqiang Ruan: Innovator in Sphingosine Research

Introduction

Fuqiang Ruan is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemistry, particularly in the area of sphingosine derivatives. With a total of 3 patents to his name, Ruan's work has implications for cancer treatment and inflammation management.

Latest Patents

Ruan's latest patents include innovative methods and compounds that target tumor cell behavior. One of his inventions focuses on trimethylsphingosine derivatives, which possess some or all of the activities of the parent compound. Another patent describes a method of inhibiting tumor cell chemotactic and chemoinvasion motility using sphingosine-1-phosphate and its derivatives. Additionally, he has developed methods to inhibit phagokinetic activity of tumor cells and neutrophils, as well as to prevent tumor cell metastasis and inflammation due to neutrophil motility.

Career Highlights

Throughout his career, Fuqiang Ruan has worked with various organizations, including Oncomembrane, Inc. and The Biomembrane Institute. His research has been pivotal in advancing our understanding of sphingosine-1-phosphate and its therapeutic potential.

Collaborations

Ruan has collaborated with esteemed colleagues such as Yasuyuki Igarashi and Sen-Itiroh Hakomori. Their joint efforts have contributed to the development of innovative solutions in the field of cancer research.

Conclusion

Fuqiang Ruan's contributions to the field of biochemistry, particularly through his patents and collaborations, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and inflammation management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…